Berirab P

Berirab P 750IU Injection is a solution containing a large amount of rabies antibodies. It is used to provide protection against rabies. It is given either along with the first dose of anti-rabies vaccine(ARV) or not more than 7 days later.

Rabies is a 100% preventable disease. Proper wound management and simultaneous administration of Berirab P 750IU Injection combined with anti-rabies vaccine (ARV) is almost invariably effective in preventing rabies, even after high-risk exposure.

Berirab P 750IU Injection is not required for patients who have previously received a complete vaccination series of rabies.

Whether Berirab P 750IU Injection is painful or not depends on your pain tolerance. During your initial treatment, a healthcare professional will put Berirab P 750IU Injection in the area where you were bitten. This can be painful. Therefore, a relatively greater amount of Berirab P 750IU Injection may be required to be placed in and around the wound site to ease out your pain and treat infection.

Equine Rabies Immunoglobulin is more economical as compared to Berirab P 750IU Injection i.e., human rabies immunoglobulin (HRIG). Hence, it is more affordable to patients in developing countries, like India. However, Equine Rabies Immunoglobulin has a high potential to cause anaphylaxis (a severe, potentially life-threatening allergic reaction), serum sickness and other allergic reactions and thus physicians are hesitant to use it.